Okada, Hideho
UCSF School of Medicine,
United States
2025 Rank: 78536
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2377 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 78536 | 78831 |
| Total Cites | 1272 | 1423 |
| H-index | 16 | 18 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 93 | 107 |
| Number of Single+First+Last Authored Papers | 109 | 109 |
| Total Cites to Single+First+Last Authored Papers | 433 | 497 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1010 | 1076 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.32 |
| Self-Citation Percentage |
10.61%
|
|
Okada, Hideho
University of California, San Francisco,
United States
2024 Rank: 73154
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2405 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 73154 | 74941 |
| Total Cites | 1275 | 1373 |
| H-index | 18 | 19 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 102 | 115 |
| Number of Single+First+Last Authored Papers | 102 | 102 |
| Total Cites to Single+First+Last Authored Papers | 442 | 478 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 985 | 1056 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.30 |
| Self-Citation Percentage |
7.14%
|
|
Okada, Hideho
University of California, San Francisco,
United States
2023 Rank: 81647
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2959 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 81647 | 78800 |
| Total Cites | 1346 | 1489 |
| H-index | 16 | 18 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 130 | 152 |
| Number of Single+First+Last Authored Papers | 100 | 100 |
| Total Cites to Single+First+Last Authored Papers | 534 | 593 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1036 | 1097 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.36 |
| Self-Citation Percentage |
9.60%
|
|
Okada, Hideho
University of California, San Francisco,
United States
2022 Rank: 47382
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1799 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 47382 | 43231 |
| Total Cites | 1318 | 1482 |
| H-index | 18 | 19 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 136 | 159 |
| Number of Single+First+Last Authored Papers | 95 | 95 |
| Total Cites to Single+First+Last Authored Papers | 574 | 654 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 989 | 1055 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.40 |
| Self-Citation Percentage |
11.07%
|
|
Okada, Hideho
University of California, San Francisco,
Mexico
2021 Rank: 68045
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2456 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 68045 | 63066 |
| Total Cites | 1654 | 1890 |
| H-index | 19 | 20 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 184 | 222 |
| Number of Single+First+Last Authored Papers | 88 | 88 |
| Total Cites to Single+First+Last Authored Papers | 715 | 833 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 1305 | 1403 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.35 |
| Self-Citation Percentage |
12.49%
|
|
Okada, Hideho
University of California, San Francisco,
United States
2020 Rank: 86901
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3021 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 86901 | 72496 |
| Total Cites | 1028 | 1207 |
| H-index | 14 | 16 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 1 | 2 |
| Number of Single+First Authored Papers | 32 | 32 |
| Total Cites to Single+First Authored Papers | 135 | 167 |
| Number of Single+First+Last Authored Papers | 83 | 83 |
| Total Cites to Single+First+Last Authored Papers | 478 | 561 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 819 | 909 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.33 |
| Self-Citation Percentage |
14.83%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.